Skip to content

Contingency management targeting increased completion of hepatitis B (Hep B) vaccination amongst people in treatment for heroin dependence

Cluster randomised controlled trial of contingency management targeting increased completion of hepatitis B (Hep B) vaccination amongst people in treatment for heroin dependence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72794493
Enrollment
192
Registered
2011-04-01
Start date
2011-02-14
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction opiate dependence Mental and Behavioural Disorders Opiate addiction

Interventions

In accordance with best clinical practice all sites will offer patients the 'super-accelerated vaccination schedule' (comprising three injections at 1, 7 and 21 days) (Department of Health, 2006
2007). The vaccination schedule offered in each site will be identical. The treatment offered will differ only in terms of the absence/presence (and type) of adjunctive incentive schedule as follows:

Sponsors

South London & Maudsley NHS Foundation Trust and Kings College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged greater than 18 years, either sex 2. New episode of opiate treatment (within first 2 months) 3. Previous, current, or at risk of engaging in risk behaviour (i.e. injecting drug use) 4. Willing to receive vaccination 5. Willing to provide informed consent

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding 2. Received prior hepatitis B vaccination course 3. Current or past hepatitis B infection

Design outcomes

Primary

MeasureTime frame
Successful completion of the three Hep B vaccination injections (days 1, 7 and 21) within 28 days. Participants will be defined as completers if they receive all three injections by day 28.

Secondary

MeasureTime frame
1. On-time attendance 2. For those who do not complete, the proportion of vaccination doses received

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026